OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)

Launched by CASE WESTERN RESERVE UNIVERSITY · Mar 15, 2022

Keywords

ClinConnect Summary

The OPTIMA-BP trial is studying how technology can help African American older adults better manage their high blood pressure (hypertension) and stick to their medication plans. High blood pressure is particularly challenging for this group, leading to serious health issues like heart disease and strokes. The trial aims to use mobile health tools, like smartphone apps and text messaging, to improve how these individuals manage their condition and ultimately lower their blood pressure.

To participate in this study, you must be at least 50 years old, identify as African American, and have high blood pressure (with a specific range). You also need to be taking at least two types of blood pressure medications and own a smartphone that can download an app. If you join, you will receive support and resources through technology to help you manage your blood pressure better. The hope is that by improving medication adherence and using technology, this trial can help close the health gap faced by African American older adults with hypertension.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Self-identify as African American
• • 2. 50 years of age or older
• • 3. Diagnosed with hypertension, with a systolic blood pressure≥ 130 mmHg but less than 170 mmHg
• • 4. Prescribed at least two hypertensive, one of which is a diuretic/thiazide and or calcium channel blocker antihypertensive medication
• • 5. Own a smartphone with a data plan, the capability to download the Medisafe app, or view videos
• • 6. Able to read/understand English
• Exclusion Criteria:
• • 1. Unable to give informed consent or judged to have impaired cognitive ability or severe memory
• • 2. Currently using a medication management application (app)
• • 3. Experienced a major CVD event or procedure (e.g., myocardial infarction, stroke, heart surgery) within the past year
• • 4. Patients with a diagnosis of chronic kidney disease (defined as estimated glomerular filtration rate (eGFR) \< 60 ml/min/1.73m2) and/or receiving dialysis.